The most award winning
healthcare information source.
TRUSTED FOR FOUR DECADES.
By Stan Deresinski, MD, FACP
Editor’s Note: Please see the special map supplement of the Balkans, which accompanies this article, enclosed with this issue of Infectious Disease Alert.
We have previously reviewed potential infectious hazards faced in the Balkans. Given the current events in that area, including the refugee crisis, the influx of NATO and relief personnel, and the possible introduction of land forces, a large number of individuals will be put at risk. For that reason, an update appears warranted.
Arboviruses and hemorrhagic fever viruses causing human disease in the Balkans include tick-borne encephalitis (TBE), Crimean-Congo hemorrhagic fever (CCHF), sandfly fever (Naples strain), and West Nile and hantaviruses.1
Tick-Borne Encephalitis (TBE). TBE viruses comprise a complex that includes eight human pathogens: Central European encephalitis (CEE), Russian spring-summer encephalitis (RSSE), Kyasur Forest disease, Omsk hemorrhagic fever, Powassan, Langat, Louping ill, and Negishi. However, the degree of homology among these viruses is such that only two, CEE and RSSE, can be considered as clearly distinct organisms.2 These have also been termed, respectively, TBE Western subtype and TBE Eastern subtype; both subtypes are present in eastern Europe.68
The tick vector, of the Ixodes ricinus, is also the vector for Borrelia burgdorferii as well as Babesia spp. in Europe. Ixodes persulcatus also serves as a vector for TBE. Outbreaks of CEE and RSSE have also resulted from ingestion of unpasteurized sheep or goat milk or cheese. In eastern Croatia, most cases occur between April and August.3 In general, RSSE is reported to occur from May to August while CEE extends its season into October.
Infection, if symptomatic (this is the case in only approximately 20%), may cause a biphasic illness, with headache, myalgia, and radiculopathy during the initial viremic phase. Aseptic meningitis is the most common clinical form of disease, occurring in approximately two infections in 1000. After initial improvement, patients suffer the abrupt onset of high fever, severe headache, and, in some cases, progressive neurologic deterioration and death. The biphasic pattern is more commonly associated with infection with the Western, rather than the Eastern, subtype of the virus. In a series of 92 cases in eastern Croatia, approximately 10% of 92 recognized cases presented with aseptic meningitis while the remainder had acute meningoencephalomyelitis. One-third had disturbed consciousness; 3.3% died.3
Approximately 85-130 cases of Central European TBE occur per annum in Yugoslavia, primarily in the northwestern area in hilly and mountainous regions of Slovenia as well as on the plains of Slovenia and Croatia. Sporadic cases have, however, also been reported from along the Adriatic coast of Croatia and in Bosnia, as well as other areas.4
An effective and well-tolerated vaccine is available in Europe (FSME-Immun Inject; Immuno, Vienna).5,6
Crimean-Congo Hemorrhagic fever (CCHF). CCHF virus is a member of the Nairovirus genus of the bunyavirus family and is transmitted by infected Hyalomma species ticks or by direct contact with animal tissues. Tick-infested migrating birds appear to play an important role in the geographic dissemination of the virus. Nosocomial transmission may also occur.7
Asymptomatic infection is uncommon. After an incubation of 2-5 days (tick transmitted) or 5-9 days (nosocomial transmission), the onset of symptoms is abrupt, with chills and high fever, severe headache and low back pain, epigastric and joint pain, and flushing of the face and chest with palatal hyperemia and petechiae. Bradycardia may occur. Leukopenia is present and thrombocytopenia are common.
The illness may have a biphasic character. At 3-5 days after onset, capillary leak and disseminated intravascular coagulation with hemorrhagic manifestations may occur. Severe hepatocellular dysfunction may also be evident. The death rate varies widely. CCHF virus is susceptible in vitro to ribavirin.8
Hantavirus Infection: Epidemic Nephropathia and Hemorrhagic Fever with Renal Syndrome (HFRS). Hantavirus infection poses a clear risk; British soldiers developed HFRS in Bosnia in 1995.9 Hantaviruses causing human disease in the Balkans include Hantaan, Dobrava/Belgrade, and Puumula. All may cause HFRS; Pumula is more frequently associated with epidemic nephropathia than the others.10-16 The normal vertebrate hosts and sources of human infection are arvicolid and murid rodents with transmission occurring via their aerosolized excrement.
Hantavirus. Infections occur in both urban and rural areas throughout the Balkans, both sporadically and in epidemic fashion, primarily from May to November.17 An epidemic of HFRS in 1986 caused more than 150 people to be hospitalized and 11 to die.18 An epidemic occurred in 1989 with 226 cases serologically documented. The fatality rate was 6.6%.
The usual incubation period is 12-21 days. Infection is commonly asymptomatic or associated with only mild self-limited symptoms, especially in those infected with Puumula virus. Puumula is also more likely to cause nephropathia epidemica, characterized by early renal involvement, often with transient renal insufficiency. Some individuals, usually among those infected with Hantaan or Belgrade virus, however, develop severe disease characterized, after a mild prodromal stage, by abrupt onset of chills, high fever, lethargy, headache and ocular pain, nausea and vomiting, backache, and flushing of the face, neck, and shoulders. Leukocytosis is commonly present at this stage.
The onset of severe signs and symptoms coincides with clearance of virus from the blood at the time of the appearance of antibody, suggesting that they may be the result of immune complex deposition. At 5-7 days after onset, patients may become hypotensive as the result of the development of a diffuse capillary leak with ensuing oliguria. Hypertension is, however, common during both the oliguric and diuretic phases.
Thrombocytopenia occurs and the development of petechiae is common.
Clinically significant hemorrhagic manifestations, resulting from disseminated intravascular coagulopathy and endothelial injury, however, occur in only 10% of severe cases. Death may ensue. Survivors generally improve rapidly, with diuresis being a harbinger of recovery.19,20
Early (within 5 days of onset) treatment of hantavirus infection in China with ribavirin appears to improve outcome, but its role in the treatment of infection with the virus endemic in the Balkans is unclear.
Sandfly fever. Among the other viral infections that may be encountered in this area is sandfly fever. Approximately 51.4% of healthy residents of the Adriatic island of Mljet had neutralizing antibody to the Naples strain of the sandfly fever virus.21 This phlebovirus usually causes asymptomatic infection or a mild self-limited illness, although it may cause aseptic meningitis.
West Nile fever. Infection with West Nile fever virus, a member of the Japanese B encephalitis virus complex of flaviviruses, is transmitted by Culex mosquitoes; its usual vertebrate hosts are wild birds.2 West Nile fever has been documented in Albania. After an incubation period of 1-6 days, a febrile illness similar to that of mild dengue may occur; rash emerges toward the end of the febrile period in approximately 50% of patients. Neurological manifestations, including meningitis and meningoencephalitis, usually occur predominantly in the elderly. However, meningitis occurred at all ages in a large outbreak in Romania in 1996.
Hepatitis viruses. Hepatitis virus infections of all sorts have a high prevalence in parts of the Balkans. Among a group of 500 pregnant Albanian refugees, HbsAg was detected in 13.4%, anti-HBc in 70.8%, anti-HAV in 96.2%, anti-HDV in 0.4%, and anti-HEV in 2%.22 A separate study of Albanian refugees found the prevalence of HbsAg to be 19% and anti-HAV to be 96%.23 In contrast, however, a serosurvey of 2142 apparently healthy individuals in Slavonski Brod, Croatia, found that only 1.8% had detectable HbsAg.24
Among 203 Croatian patients with chronic HCV infection, 61.1% were infected with genotype 1b, 26.1% with 3a, and 10.8% with 1a.25 Antibody to hepatitis E was detected in 4.9% of 350 southern Albanian refugees.26 HGV RNA was detected in seven (11.9%) and HGV E2 antibody in 20 (33.9%) of 59 Slovenian hemodialysis patients.28
HIV. The prevalence of HIV infection among 551 injection drug users from the area of Belgrade tested between 1987 and 1992 was 43.7%, but HIV prevalence was only 4.6% among individuals from other urban areas.28 Similarly, a report published in 1990 indicated that nearly 50% of injection drug users imprisoned in Belgrade were HIV infected.29 It is of interest that the protective CCR5D32 homozygous mutation was present in only two (0.5%) of 385 nonHIV-infected individuals in Slovenia.30
Childhood viruses. The lack of vaccination against childhood diseases in many areas will lead to a resurgence of these diseases. It was reported in 1992 that 41.3% of recent Albanian emigres to Italy lacked antibody to poliovirus type 3 and that 21% lack antibody to poliovirus type 1.31 An outbreak of wild type 1 poliovirus infection, which began in Albania in 1996, subsequently spread to Yugoslavia and Greece.32 Of 145 affected patients who were identified, 87 had persisting paralysis and 16 died.
In 1976, an outbreak of rubella in Croatia affected 2746 individuals, 79.1% of whom were male.33 In April 1996, four British military helicopter ground crew deployed to Bosnia-Herzegovina developed rubella.34
Rabies. Rabies is endemic in the Balkans. Dog bites were reported by 62 British soldiers during the first six months of their peacekeeping mission in Bosnia.35
Bacterial infections. Anthrax and brucellosis remain potential hazards and outbreaks of tularemia have been reported).4,36-38 Typhoid fever occurs, sometimes in epidemic form.39
Tuberculosis is highly prevalent; 0.55% of Yugoslav immigrants to Switzerland between 1988 and 1990 had radiographic evidence of pulmonary tuberculosis.40,41 Leprosy is reported in the Balkans.42,43
An outbreak of infection due to Vibrio cholerae 01 El Tor occurred in Albania (and Italy) in 1994. All isolated strains were resistant to tetracycline, streptomycin, spectinomycin, trimethoprim, and sulfathiazole.44 As of press time, the Balkans are not on the USPHS list of "cholera-infected countries."
The conditions of crowding, poverty, and inadequate hygiene provide a circumstance ideal for lice infestations and, therefore, the likelihood of infection with the agent of trench fever, Bartonella quintana.
Spirochetal infections. Spirochetal infections that may be encountered include syphilis, leptospirosis, and Lyme borreliosis disease.45 Lyme disease is highly endemic in Slovenia and is undoubtedly present elsewhere in the Balkans as well.46 Borrelia spp. were isolated from the midgut of 69 (10%) of 363 ticks (I. ricinus), including 26 (13%) of 206 nymphal stage organisms in Slovenia.47 Of 60 isolates that were speciated using PCR, 53% were Borrelia afzelii, 33% were Borrelai garinii, and 8% were B. burgdorferii sensu stricto. In 1994, B. burgdorferii sensu lato was isolated from 231 patients with erythema migrans at the University Medical Center in Ljubljana, Slovenia. Observations suggest that early infection might be milder in Slovenia than in the United States.49,50
Rickettsial infections. Rickettsial infections represent potential hazards in this region. A serosurvey involving 231 individuals in northwestern Bosnia-Herzegovina found that 61.5% had complement-fixing antibody to R. typhi, 4.3% to Rickettsia prowazekii, 1.7% to R. conorii, and 19.0% to C. burnetii. Testing by an indirect immunofluourescent assay found somewhat different results, with 37.7% being positive for R. typhi, 1.6% for R. conorii, and 22.4% for C. burnetii.50 A survey of residents of coastal Croatia found that 4.2-5.0% had antibody to R. conorii.51
Brill-Zinsser disease (recrudescent typhus) may still be seen in individuals from areas with previously active foci of infection and louse-borne typhus was widespread in Bosnia during, and for at least a decade after, the second World War. In addition, more than 57 outbreaks were documented to have occurred between 1957 and 1980.4 Murine typhus may also be encountered; 63-68% of inhabitants of the northern Dalmatian islands had detectable antibody to R. typhi.52
Rickettsia akari, the agent of rickettsialpox, has been recovered from a patient in Croatia.53
Human granulocytic ehrlichiosis is present in Slovenia.54,55
Mycoses. Seventeen patients with rhinosporidiosis were identified in northern Serbia over a two-year period; all had bathed in the same stagnant lake.56
Parasitic infections. Intestinal infestations with Enterobias vermicularis, Ascaris lumbricoides, Trichuris trichiura (as well as Giardia lamblia) are highly prevalent among school-age children in many areas of Serbia.57 Stool examination of 5981 school children in central Serbia from 1984-1993 found the following prevalences: Entamoeba histolytica, 0.02%; G. lamblia, 6.8%; Hymenolepsis nana, 0.06%; E. vermicularis, 14.7%; A. lumbricoides, 3.3%; and T. trichura, 1.8%.58
Yugoslavia, along with Greece, Spain, and northern Portugal, has the highest rates of echinococcosis due to Echinococcus granulosus in Europe. The areas with the highest prevalence within Yugoslavia are Dalmatia and Montenegro.59 Taenia saginata and T. solium infection, including cysticercosis, may occur. Approximately 4.7% of swine in one area had serological evidence of Trichenella spiralis infection and human trichinosis was seen.60 Another study found that 22% of grazing pigs and 1.67% of pigs raised on small farms were infected.61 Hookworm has been endemic in Yugoslavia.
Heterophyiasis (dwarf fluke infection), which results from ingesting raw or undercooked freshwater cyprinoid or salmonoid fish (salted and pickled fish may also be risky) containing metacercariae, is seen.4
The seroprevalence of toxoplasmosis in female residents of Belgrade ages 15-45 years was reported in 1998 to be 77%.62 The incidence of congenital toxoplasmosis in Slovenia was reported in 1992 to be three per 1000 live births.63
Leishmaniasis, both cutaneous and visceral, may be acquired in Yugoslavia.65,66 Cutaneous leishmaniasis is said to be currently rare in continental areas where it had previously been endemic but is still a risk in some coastal regions and on islands in the Adriatic. More than 200 cases of visceral leishmaniasis were reported from 1940-1980, but this infection is now only infrequently identified.4
The first human case of babesiosis in Europe was reported from Yugoslavia in 1957.66 Most European cases are due to Babesia divergens, a cattle pathogen. The infection is transmitted by I. ricinus.
Envenomation. Venomous snake bites pose a danger in the Balkans. Physicians at the Clinical Hospital in Split, Croatia, encountered 389 victims bitten by the horned viper between 1980 and 1996.67
All childhood vaccines should be up to date; fully vaccinated adults should receive a polio vaccine booster prior to travel. Measles and diphtheria-tetanus toxoid boosters may also be indicated. Consideration should be given to receiving vaccination against tick-borne encephalitis virus (not available in the United States), as should rabies vaccination. Typhoid vaccination is indicated and hepatitis A vaccination are indicated; hepatitis B vaccination is desirable. Influenza vaccination should be used in season. Those working in refugee camps should consider meningococcal vaccination, as well as pneumococcal vaccination.
Food should be well cooked. Precautions should be taken with drinking water. Protection against insect and arthropod bites is important. Long-sleeved shirts and long pants should be worn, DEET-containing insect repellent should be used, and permethrin should be applied to clothing. Inspection for the presence of ticks should be performed regularly. This is of great importance given the large number of potentially tick-borne diseases that may be encountered such as TBE, Lyme disease, human granulocytic ehrlichiosis, rickettsial infections, babesiosis, and tularemia. The Lyme disease vaccine available in the United States is not effective in preventing infection by the Borrelia species most encountered in Europe.
An antibiotic, such as a fluoroquinolone, should be carried, along with loperamide, for empiric treatment of diarrheal illness. After return, medical evaluation, including PPD testing, may be indicated.
1. Vesenjak-Hirjan J, et al. J Hyg Epidemiol Microbiol Immunol 1991;35:129-140.
2. Monath TP, Tsai TF. Flaviviruses. In: Whitman Whitly R, Hayden F, eds. Clinical Virology. New York: Churchill Livingstone; 1997:1133-1185.
3. Anic K, et al. Scand J Infect Dis 1998;30:509-512.
4. Wilson ME. A World Guide to Infections. New York: Oxford University Press; 1991.
5. Grzeszczuk A, et al. Infection 1998;26:385-388.
6. McNeil JG, et al. J Infect Dis 1985;152:650-651.
7. Johnson KM. Hemorrhagic fevers: A comparative appraisal. In: Whitman Whitly R, Hayden F, eds. Clinical Virology. New York, NY: Churchill Livingstone; 1997:149-158.
8. Gorbach S, Bartlett J, Blacklow N. Infectious Diseases. Philadelphia: WB Saunders; 1992:1849-1852.
9. British soldier returns from Bosnia with HFRS. Com mun Dis Rep CDR Wkly 1995;5:193.
10. Mertz GJ. Bunyaviridae: Bunyaviruses, phleboviruses, nairoviruses, and hantaviruses. In: Whitman Whitly R, Hayden F, eds. Clinical Virology. New York, NY: Churchill Livingstone; 1997:943-972.
11. Antoniadis A, et al. J Infect Dis 1996;174:407-410.
12. Polenakovic M, et al. Artif Organs 1995;19:808-813.
13. Lundkvist A, et al. J Med Virol 1997;53:51-59.
14. Bogdanovic R, et al. Pediatr Nephrol 1999;8:299-303.
15. Gligic A, et al. J Infect Dis 1992;166:113-120.
16. Diglisic G, et al. J Infect Dis 1994;169:204-207.
17. Clement J, et al. Lancet 1994;344:131.
18. Gligic A, et al. Eur J Epidemiol 1992;8:816-825.
19. Anonymous. Lancet 1990;336:407-408.
20. Gligic A, et al. J Infect Dis 1992;166:113-120.
21. Punda-Polic V, et al. Acta Med Iugosl 1990;44:15-20.
22. Malamitsi-Puchner A, et al. Eur J Epidemiol 1996;12: 297-301.
23. Santantonio T, et al. Eur J Epidemiol 1993;9:537-540.
24. Jelic O, et al. Acta Med Croatica 1994;48:111-116.
25. Vince A, et al. Infection 1998;26:173-177.
26. Dalekos GN, et al. Transfusion 1998;38:589-595.
27. Seme K, et al. Nephron 1998;79:426-429.
28. Kilibarda M. Bull Narc 1993;45:135-146.
29. Radovanovic Z, et al. J Hyg Epidemiol Microbiol Immunol 1990;34:27-29.
30. Poljak M, et al. Acta Virol 1998;42:23-26.
31. Squarcione S, et al. Vaccine 1992;10:853-856.
32. Fiore L, et al. J Clin Microbiol 1998;36:1912-1918.
33. Bakasun V, Suzanic-Karnincic J. Int J Epidemiol 1995;24:453-456.
34. Adams MS, et al. Epidemiol Infect 1999;118:253-257.
35. Croft A, Archer R. Br J Gen Pract 1997;47:435-437.
36. Bradaric N, Vilic N. Lijec Vjesn 1992;114:122-126.
37. Canova CR, et al. Schweiz Med Wochenschr 1993;123: 2370-2377.
38. Borcic B, et al. Folia Parasitol (Praha) 1976;23: 257-265.
39. Bradaric N, et al. Eur J Epidemiol 1996;12:409-412.
40. Raviglione MC, et al. Tuber Lung Dis 1994;75:400-416.
41. Bonvin L, Zellweger JP. Tuber Lung Dis 1992;73: 322-325.
42. Nakuci M. Indian J Lepr 1992;64:385-388.
43. Stanimirovic A, et al. Lepr Rev 1995;66:318-323.
44. Falbo V, et al. Chemother 1999;43:693-696.
45. Sebek Z, et al. Folia Parasitol (Praha) 1972;19:53-60.
46. Strle F, et al. Eur J Epidemiol 1996;12:503-507.
47. Strle F, et al. Eur J Clin Microbiol Infect Dis 1995;14: 994-1001.
48. Strle F, et al. Clin Infect Dis 1997;25:273-280.
49. Strle F, et al. Clin Infect Dis 1996;23:61-65.
50. Punda-Polic V, et al. Eur J Epidemiol 1995;11: 697-699.
51. Radulovic S, et al. J Clin Microbiol 1993;31:2225-2227.
52. Dobec M, Hrabar A. J Hyg Epidemiol Microbiol Immunol 1990;34:175-181.
53. Radulovic S, et al. Clin Infect Dis 1996;22:216-220.
54. Lotric-Furlan S, et al. Clin Infect Dis 1998;27: 424-428.
55. Petrovec M, et al. J Clin Microbiol 1997;35:1556-1559.
56. Vukovic Z, et al. J Trop Med Hyg 1999;98:333-337.
57. Nikolic A, et al. J Chemother 1995;7:55-57.
58. Nikolic A, et al. Srp Arh Celok Lek 1998;126:1-5.
59. Morovic M. Epidemiol Infect 1997;119:271-276.
60. Clausen MR, et al. QJM 1996;89:631-636.
61. Marinculic A, et al. Southeast Asian J Trop Med Public Health 1991;22 Suppl:302-307.
62. Bobic B, et al. Eur J Epidemiol 1998;14:605-610.
63. Logar J, et al. Scand J Infect Dis 1992;24:105-108.
64. Matzdorff AC, et al. Dtsch Med Wochenschr 1997;122: 890-894.
65. Wenzl Het, et al. Wien Klin Wochenschr 1992;104: 757-760.
66. Brasseur P, Gorenflot A. Rocz Akad Med Bialymst 1996;41:117-122.
67. Radonic V, et al. Mil Med 1997;162:179-182.
68. Dumpis U, et al. Clin Infect Dis 1999;28:882-890.